|
|
||||||||
![]() |
|
|||||||
|
|
||||||||
|
|
||||||||
![]() |
|
|||||||
|
By Jeroen Cammeraat, COO, Nucletron
In radiation therapy, it is standard practice for delivery-system vendors to
provide their own brands of treatment planning software. The theory is that the
software and hardware capabilities should be ideally matched. In practice,
however, this “packaged solution” approach has created limitations that are growing more problematic for
clinicians as technology advances and treatment options increase.
We hear concerns about increasingly complex user interfaces that are difficult
to navigate. Vendor development schedules dictate and sometimes delay the
treatment options that physicians can offer to patients. The linking of
treatment planning to the delivery platform also creates silos. These planning
silos make it difficult for physicians to compare alternative plans or to
create customized plans that combine treatment modalities.
A new vision for open treatment planning
Nucletron is a well-known vendor of brachytherapy afterloaders, but we have a
different vision for treatment planning. We think customers should have more
flexibility. We believe physicians should have the freedom to choose their
patient-planning environment irrespective of the treatment delivery vendor. I
am pleased to introduce you—or reintroduce you—to Oncentra®, an independent treatment planning system that gives you the freedom of choice.
The Oncentra Dynamic Planning Environment is an open system that is and will
remain compliant with DICOM standards. In fact, Nucletron is fully committed to
supporting and advancing the development of DICOM and IHE-RO standards. Our
adherence to open standards means that treatments planned in Oncentra can be
used in any treatment delivery environment. As a result, radiation oncology
departments don’t have to cast their lot with one linac vendor; they can make choices based on
their own goals.
Oncentra is also a multimodality planning system that supports image-guided
photon, electron, proton, and brachytherapy. Both brachytherapy and external
beam treatments can be planned in the Oncentra Environment using many of the
same tools, and we’ve recently added the capability to plan volumetric arc therapy treatments.
Physicians have told us that they want to be able to compare arc therapy plans
to standard IMRT plans so they can choose the best option for the patient. With
our new arc therapy planning module, Oncentra VMAT, they can do just that.
User choice + rapid innovation
We think that a universal planning environment for all modes of radiation
therapy will enhance the quality of treatment plans. It will also improve
productivity, especially if users love the interface. We are working diligently
on providing an efficient, modern interface that provides the best user
experience.
Another strength of Oncentra is its modular architecture, which enables fast
implementation and adoption of new innovations. We believe that time-to-market
with new and improved capabilities is more important than who invents the idea.
We welcome commercial and clinical collaborations that support the goal of
better patient care. Our work with RaySearch Laboratories, for example, helped
us to rapidly deliver Oncentra VMAT.
I’ve touched on the principles that underpin the Oncentra Environment: user choice
and rapid innovation. Where are we headed? We are creating a dynamic
environment for managing offline, online, and real-time planning. Ultimately
our goal is to provide guided, patient-centric decision-making and evaluation
tools that personalize care based on your choice of modality and the latest,
most effective treatment techniques.
I hope you will give Oncentra software a close look, because customers are
telling us that the time has come for an independent planning environment. We
are listening.
|
|
|||||||
![]() |
|
|||||||
|
|
||||||||
|
“We think that a universal planning environment for all modes of radiation
therapy will enhance
the quality of treatment plans.”
Jeroen Cammeraat, COO, Nucletron
|
|
|||||||
|
|
||||||||
|
|
||||||||
|
|
|
|
|
|
|
|
|
|